“…Unsurprisingly, errors in selective transport can lead to cellular dysregulation. Aberrant nucleocytoplasmic transport has been implicated in aging, neurodegenerative disorders (e.g., amyotrophic lateral sclerosis, Alzheimer’s disease, frontotemporal dementia, Huntington’s disease, Parkinson’s disease), viral infections, autoimmune disorders, and cancer [ 24 , 25 , 26 , 27 ]. In pathological conditions, Nups and/or NPC associated proteins can have missense mutations [ 28 ], protein alterations (e.g., truncation, fusion) [ 29 , 30 ], and anomalous expressions [ 31 , 32 ].…”